Silence Therapeutics (LON:SLN) Shares Pass Below 200 Day Moving Average – What’s Next?

Silence Therapeutics plc (LON:SLN)’s share price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 535 ($6.79) and traded as low as GBX 512 ($6.50). Silence Therapeutics shares last traded at GBX 535 ($6.79), with a volume of 913,528 shares.

Silence Therapeutics Stock Performance

The stock’s 50-day simple moving average is GBX 535 and its 200-day simple moving average is GBX 535. The stock has a market cap of £480.35 million and a price-to-earnings ratio of -11.01. The company has a current ratio of 4.52, a quick ratio of 4.36 and a debt-to-equity ratio of 0.80.

Silence Therapeutics Company Profile

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver.